Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Deciphering Tumorigenesis Driven by Replication-Associated DNA Damage

This « Allocated Fund in Genetics and Genomics » was granted in January 2019 to Prof. Massimo Lopes (University of Zurich) and to Prof. Achim Weber…

More information

lnvestigating the Functional Role of Cellular Phenotypes in Melanoma Targeted Therapy

This “Allocated Fund in oncogenic signaling” was granted in January 2019 to Prof. Reinhard Dummer (Department of Dermatology, University Hospital…

More information

Flash Radiotherapy

This “allocated fund” from the Biltema Foundation was granted in July 2016 for 3 years.

Research laboratory of Prof. Jean Bourhis (CHUV/UNIL)

More information

News & Events

Posted on

Congratulations to Prof. Douglas Hanahan who is being appointed Distinguished Scholar of Ludwig. A pioneering molecular biologist and renowned cancer…

Read more
Posted on

World Cancer Day takes place every year on February 4 to unite the world in the fight against cancer. This day aims to raise awareness by spreading…

Read more
Posted on

Congratulations to Efe Erdes for his publication in the “Journal for ImmunoTherapy of Cancer”. His article describes the chronic TCR-MHC interactions…

Read more
Posted on

Congratulations to Prof David Gfeller (UNIL/SIB), Dr. Michal Bassani-Sternberg (CHUV/UNIL) and Julien Racle (UNIL/SIB): the results of their work…

Read more